TYP 8.11% 2.0¢ tryptamine therapeutics limited

There’s sustained buying at above previous volumes.imho it’s...

  1. Al.
    198 Posts.
    lightbulb Created with Sketch. 114
    There’s sustained buying at above previous volumes.
    imho it’s unlikely to be a forum generated response.
    the marked change in demand seems to correlate with Codiaks announcement of safety for 5 healthy patients with their exoIL-12 product.

    the huge previous breakthroughs in cancer have come from essentially unlocking the brakes in the human immune system - called Cart-t therapy
    they called this therapy a miracle for cancer but it has three major limitations - the first is its inability to target solid tumours - hence only providing the huge response rates in blood cancers, second is the very severe nature of unleashing the power of the immune system without brakes on- can cause a deadly side effect, the third is the huge cost as it is created from cells from the individual - it cannot be packaged and must be made individually and specifically then transported ‘live’ back to the patient’

    could exosomes safely facilitate select components of the immune system which have efficacy against tumors to be directly ‘drawn’ to the Tumor site at ‘volume’ and without systemic issues?


    https://www.globenewswire.com/fr/news-release/2020/12/30/2151648/0/en/Codiak-Reports-Positive-Initial-Phase-1-Results-for-exoIL-12-Demonstrating-Tolerability-and-Absence-of-Systemic-IL-12-Exposure-in-Healthy-Volunteers.html
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
0.002(8.11%)
Mkt cap ! $21.78M
Open High Low Value Volume
1.9¢ 2.0¢ 1.9¢ $57.60K 2.928M

Buyers (Bids)

No. Vol. Price($)
4 1076509 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 277183 2
View Market Depth
Last trade - 16.10pm 10/07/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.